News

Enter your email address to get Core One Labs News Alerts.

News

Enter your email address to get Core One Labs News Alerts.
Company News
July 19, 2023
Core One Applauds California Assembly Health Committee’s Approval of Bill to Legalize Psychedelics
Vancouver, British Columbia, Canada – July 19, 2023 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
July 11, 2023
Core One’s Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin
Vancouver, British Columbia, Canada – July 11, 2023 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU)...
Read more
Company News
July 07, 2023
Core One’s Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method
Vancouver, British Columbia, Canada – July 7, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6,...
Read more
Company News
June 26, 2023
Core One Labs Applauds FDA’s Draft Guidance on Clinical Trials for Psychedelic Drugs
Vancouver, British Columbia, Canada – June 26, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the...
Read more
Company News
May 05, 2023
Core One in Talks with Multiple Companies to Supply Psilocybin
Vancouver, British Columbia, Canada – May 5, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:...
Read more
Company News
May 01, 2023
Core One Labs’ GMP Drug Takes Further Steps Toward Commercialization: Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy
Vancouver, British Columbia, Canada – May 1, 2023 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:...
Read more